rs192327462

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_012179.4(FBXO7):​c.122+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00546 in 1,540,668 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0039 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0056 ( 25 hom. )

Consequence

FBXO7
NM_012179.4 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.0480

Publications

0 publications found
Variant links:
Genes affected
FBXO7 (HGNC:13586): (F-box protein 7) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it may play a role in regulation of hematopoiesis. Alternatively spliced transcript variants of this gene have been identified with the full-length natures of only some variants being determined. [provided by RefSeq, Jul 2008]
FBXO7 Gene-Disease associations (from GenCC):
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 22-32475133-G-A is Benign according to our data. Variant chr22-32475133-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 341307.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00393 (598/152318) while in subpopulation NFE AF = 0.00706 (480/68012). AF 95% confidence interval is 0.00654. There are 3 homozygotes in GnomAd4. There are 260 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012179.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO7
NM_012179.4
MANE Select
c.122+9G>A
intron
N/ANP_036311.3
FBXO7
NM_001033024.2
c.-229G>A
upstream_gene
N/ANP_001028196.1Q9Y3I1-2
FBXO7
NM_001257990.2
c.-486G>A
upstream_gene
N/ANP_001244919.1Q9Y3I1-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO7
ENST00000266087.12
TSL:1 MANE Select
c.122+9G>A
intron
N/AENSP00000266087.7Q9Y3I1-1
FBXO7
ENST00000886524.1
c.122+9G>A
intron
N/AENSP00000556583.1
FBXO7
ENST00000920428.1
c.122+9G>A
intron
N/AENSP00000590487.1

Frequencies

GnomAD3 genomes
AF:
0.00394
AC:
599
AN:
152210
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00137
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00103
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00706
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00311
AC:
425
AN:
136722
AF XY:
0.00308
show subpopulations
Gnomad AFR exome
AF:
0.000548
Gnomad AMR exome
AF:
0.000747
Gnomad ASJ exome
AF:
0.00138
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00162
Gnomad NFE exome
AF:
0.00706
Gnomad OTH exome
AF:
0.00249
GnomAD4 exome
AF:
0.00563
AC:
7820
AN:
1388350
Hom.:
25
Cov.:
32
AF XY:
0.00546
AC XY:
3736
AN XY:
684556
show subpopulations
African (AFR)
AF:
0.000856
AC:
26
AN:
30358
American (AMR)
AF:
0.000792
AC:
28
AN:
35362
Ashkenazi Jewish (ASJ)
AF:
0.00193
AC:
48
AN:
24918
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35086
South Asian (SAS)
AF:
0.000510
AC:
40
AN:
78482
European-Finnish (FIN)
AF:
0.00185
AC:
86
AN:
46364
Middle Eastern (MID)
AF:
0.00179
AC:
8
AN:
4464
European-Non Finnish (NFE)
AF:
0.00686
AC:
7381
AN:
1075850
Other (OTH)
AF:
0.00353
AC:
203
AN:
57466
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
444
889
1333
1778
2222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00393
AC:
598
AN:
152318
Hom.:
3
Cov.:
33
AF XY:
0.00349
AC XY:
260
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41582
American (AMR)
AF:
0.00189
AC:
29
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.00103
AC:
11
AN:
10628
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00706
AC:
480
AN:
68012
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00507
Hom.:
1
Bravo
AF:
0.00384
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Parkinsonian-pyramidal syndrome (4)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
6.9
DANN
Benign
0.95
PhyloP100
-0.048
PromoterAI
0.056
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192327462; hg19: chr22-32871120; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.